uric acid has been researched along with baicalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Y; Jiang, Y; Li, L; Li, Y; Lin, C; Pang, J; Tian, Y; Wu, T; Yang, Y; Zhao, Z; Zhou, P | 1 |
| Lei, H; Li, Y; Liu, Y; Liu, Z; Qiu, Y; Xiang, H; Xu, L | 1 |
| Deng, Q; Fu, W; Li, Y; Liu, Z; Mei, Z; Qiu, Y; Xiang, H; Xu, L; Yu, Z | 1 |
3 other study(ies) available for uric acid and baicalein
| Article | Year |
|---|---|
Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Topics: Animals; Antioxidants; Disease Models, Animal; Enzyme Inhibitors; Flavanones; Glucose Transport Proteins, Facilitative; HEK293 Cells; Humans; Hyperuricemia; Kidney; Liver; Male; Mice; Molecular Docking Simulation; Organic Anion Transporters; Organic Cation Transport Proteins; Oxonic Acid; Uric Acid; Xanthine Oxidase | 2021 |
Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy.
Topics: Allopurinol; Animals; Blood Urea Nitrogen; Flavanones; Flavonoids; Kidney Diseases; Liver; Mice; Molecular Docking Simulation; Uric Acid; Xanthine Oxidase | 2021 |
Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF-κB signalling pathway.
Topics: Animals; Hyperuricemia; Inflammation; Mice; Molecular Docking Simulation; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Uric Acid | 2023 |